MEA Mammography Market

MEA Mammography Market Size (2022 to 2027)

The Middle East & Africa mammography market is estimated to be around USD 103.22 million in 2022. It is projected to reach USD 122.48 million by the end of 2027, growing at a compound annual growth rate (CAGR) of 4.2% between 2022 to 2027.

The growing number of breast cancer cases across the MEA is majorly boosting the mammography market growth in MEA. Breast cancer is among the most common cancers seen among the female population. The mammography technique helps detect early signs of breast cancer when women cannot experience any symptoms. Due to the increasing mortality rate among women, the demand for mammography screening has increased, resulting in increasing market growth.

The growing awareness among the women population regarding the treatment options for breast cancer in MEA is another notable factor contributing to the regional market growth. Due to the increasing literacy rate among the women population, all these people know about the consequence of breast cancer and the benefits of early detection of breast cancer through mammography screening. The government conducts several awareness programs on women's special days like women's days etc to know about the importance of having breast screening after 35 years of age. Few companies also provide free mammography screening programs to their female employees. All these factors help the market growth during the forecast period.

The growing adoption of technological advancements in the development and manufacturing of mammography devices and increasing investments by the key market players are propelling the mammography market in MEA. Breast tomosynthesis is the advanced form of 3D mammography which uses a lower dose of X-rays and produces images of the breast which helps to detect cancer. In addition, advanced technologies such as machine learning, deep learning, and image processing are used to analyze breast cancer images which help to detect normal or abnormal lesions in mammography techniques. Manufacturers and key players are focused on developing advanced devices for breast cancer screening and improving the image quality for detecting cancer cells or abnormal cells in the breast.

Furthermore, the growing number of R&D for the advancements in mammography, the presence of favorable reimbursement policies, and increasing product approvals support the mammography market growth in MEA.

On the other hand, side effects of radiation exposure and risk due to screening primarily hampers the growth of the mammography market in MEA. The scarcity of more skilled professionals and lack of proper infrastructure further hinder the regional market growth. Poor awareness regarding the benefits of mammography is inhibiting the growth rate of the market.

This research report on the Middle East and Africa mammography market has been segmented and sub-segmented into the following categories:

By Product: 

• 3D mammograms
• Digital
• Analog system
• Film Screens
• Biopsy Systems
• Others

Based on product, the digital segment accounted for the major share of the market in 2022.

By Technology: 

• Analog
• Digital
• Breast tomosynthesis

Based on technology, the digital segment is anticipated to lead the market throughout the forecast period.

By Application: 

• Screening
• Diagnostics

The screening segment captured the leading share of the MEA market in 2022.

By Country: 

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

The MEA market accounted for a moderate share of the worldwide market in 2021 and is expected to grow at a steady CAGR during the forecast period.

The market in Egypt is expected to account for the leading share of the MEA market during the forecast period. Nearly 33% of women in Egypt have breast cancer, and 22,000 new cases are diagnosed yearly. As per the survey in the year 2020, one woman dies of breast cancer every 57 minutes. Over the past few years, increasing breast cancer cases in Egypt has resulted in increasing breast screening programs.

Saudi Arabia is another notable regional market for mammography in MEA and is expected to grow at a healthy CAGR owing to the increasing number of screening programs. The government of Saudi Arabia has taken several initiatives, such as mammography must be taken by women aged between 50-69 years every two years. In addition, an increasing number of breast cancer centers also helps the market grow.

UAE is expected to register a notable CAGR during the forecast period due to increasing awareness programs by the government. For example, in Dubai, breast cancer awareness month is conducted every year in October. The programs help to raise awareness about chronic disease and encourage early detection of breast cancer.

KEY MARKET PLAYERS:

Companies playing a leading role in the Middle East & Africa mammography market profiled in the report include Fujifilm, GE Healthcare, Hologic, Metaltronica, Philips Healthcare, Planmed, Siemens Healthcare, Sonocine, and Toshiba Medical Systems.